Article Text
Abstract
Libertarian paternalism describes the idea of nudging—that is, steering individual decision-making while preserving freedom of choice. In medicine, libertarian paternalism has gained widespread attention, specifically with respect to interventions designed to promote healthy behaviours. Some scholars argue that nudges appropriately balance autonomy and paternalistic beneficence, while others argue that nudges inherently exploit cognitive weaknesses. This paper further explores the ethics of libertarian paternalism in public health. The use of nudges may infringe on an individual’s voluntary choice, autonomy and informed consent, but they are ethically justified when there is a clear public health benefit to the manipulation of choice.
- public health ethics
- coercion
- decision-making
- informed consent
- public policy
Data availability statement
There are no data in this work.
Statistics from Altmetric.com
Data availability statement
There are no data in this work.
Footnotes
Contributors DS is the sole contributor to this manuscript. He conceptualised the idea and drafted the piece.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Primary goals, information-giving and men’s understanding: a qualitative study of Australian and UK doctors’ varied communication about PSA screening
- A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening—a qualitative analysis
- Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
- Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening
- Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study
- Prostate cancer screening and the management of clinically localized disease
- Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
- Screening for prostate cancer remains controversial
- Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
- Increasing the uptake in a general practice prostate cancer screening programme